DurAVR™ THV System

About Anteris Technologies

Anteris Technologies is a clinical-stage medical device company focused on developing superior solutions for structural heart disease, with a primary emphasis on aortic stenosis. Its core innovation is the DurAVR™ transcatheter heart valve system, engineered to mimic the native aortic valve's anatomy and function, aiming to overcome limitations of current TAVR devices related to hemodynamics and long-term durability. The company is publicly listed on the Australian Securities Exchange (ASX: AVR) and is progressing its pivotal clinical program to validate the DurAVR™ system's performance. Anteris's mission is to set a new standard in heart valve therapy by delivering a valve that performs like a patient's own.

About Anteris Technologies

Anteris Technologies is a clinical-stage medical device company focused on developing superior solutions for structural heart disease, with a primary emphasis on aortic stenosis. Its core innovation is the DurAVR™ transcatheter heart valve system, engineered to mimic the native aortic valve's anatomy and function, aiming to overcome limitations of current TAVR devices related to hemodynamics and long-term durability. The company is publicly listed on the Australian Securities Exchange (ASX: AVR) and is progressing its pivotal clinical program to validate the DurAVR™ system's performance. Anteris's mission is to set a new standard in heart valve therapy by delivering a valve that performs like a patient's own.

Therapeutic Areas